Cite
Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer.
MLA
Garden, Adam S., et al. “Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer.” International Journal of Radiation Oncology, Biology, Physics, vol. 117, no. 2, Oct. 2023, pp. 333–40. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2023.02.057.
APA
Garden, A. S., Harris, J., Eisbruch, A., Chao, K. S. C., Morrison, W. H., Harari, P. M., Swanson, T. A., Jones, C. U., Yom, S. S., Spencer, S. A., Scrimger, R., Shenouda, G., Shukla, M., Lau, H. Y., Mierzwa, M., Torres-Saavedra, P., & Le, Q. T. (2023). Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer. International Journal of Radiation Oncology, Biology, Physics, 117(2), 333–340. https://doi.org/10.1016/j.ijrobp.2023.02.057
Chicago
Garden, Adam S, Jonathan Harris, Avraham Eisbruch, K S Clifford Chao, William H Morrison, Paul M Harari, Todd Allen Swanson, et al. 2023. “Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer.” International Journal of Radiation Oncology, Biology, Physics 117 (2): 333–40. doi:10.1016/j.ijrobp.2023.02.057.